SCHEMBL25849409

SCHEMBL25849409

Cc1cc(Cl)cc(Oc2cccc(-c3c(C)[nH]c4c(c3=O)CCCC4)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.42
CREBBP Q92793 1/20 0.39
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
SLC2A1 P11166 1/20 0.37
BCHE P06276 4/20 0.36
ACHE P22303 4/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25849457 0.95 BRD4 (0.44) BRD4CREBBPNR1H2NR1H3SLC2A1
SCHEMBL25849454 0.89 SLC2A1 (0.49) BRD4CREBBPSLC2A1BCHEACHE
SCHEMBL25849408 0.87 BRD4 (0.45) BRD4CREBBPSLC2A1BCHEACHE
SCHEMBL25849459 0.86 BRD4 (0.41) BRD4CREBBPNR1H2NR1H3SLC2A1
SCHEMBL29768819 0.85 SLC2A1 (0.49) BRD4CREBBPSLC2A1BCHEACHE
SCHEMBL19047283 0.85 SLC2A1 (0.49) BRD4CREBBPSLC2A1BCHEACHE
SCHEMBL24046937 0.84 BRD4 (0.45) BRD4CREBBPNR1H2NR1H3SLC2A1
SCHEMBL19032416 0.82 SLC2A1 (0.53) BRD4CREBBPSLC2A1KDM4EMEN1
SCHEMBL25849456 0.80 NR1H2 (0.41) BRD4CREBBPNR1H2NR1H3KDM4E
SCHEMBL25849453 0.80 BRD4 (0.41) BRD4CREBBPNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites THE UNIVERSITY OF SHEFFIELD (GB) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites CYP11B2, CYP11B1, COX5B BRD4 855/4885CREBBP 1678/4885NR1H2 191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.